Welcome to

PIANOFORTE

Our mission
Launched in 2022 with 58 partners and coordinated by the French Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), the European partnership for radiation protection research contributes to improving the protection of the public, workers, patients and the environment from environmental, occupational and medical exposure to ionising radiation.
As of January 2025, it involves more than 100 partners from 22 European Union countries, 5 non-EU countries and the 6 European research platforms in radiation protection (MELODI, EURADOS, EURAMED, NERIS, ALLIANCE and SHARE). It is co-financed by the European Union’s EURATOM programme and the governments of the participating countries.
Through its research activities implemented by Open call’s awarded research projects, PIANOFORTE contributes to European policies such as the European plan to combat cancer, the green pact for growth, and the implementation of the roadmap for reducing industrial and natural risks.

Our impact
By establishing a comprehensive pan-European scientific and technological foundation, PIANOFORTE aims to support a robust radiological protection system and to develop consolidated, science-based policy recommendations for decision-makers across diverse sectors that utilise ionising radiation, both energy and non-energy related.


PIANOFORTE White Paper:
Advocating for the Future of Radiation Protection Research in Europe


We are pleased to announce the release of our White Paper, "The Vital Role of Radiation Protection Research in Europe's Future". This key document underscores the critical need for sustained investment in radiation protection research for the Next Euratom Research and Training Programme under the Tenth Framework Programme for Research and Innovation (FP10).

PIANOFORTE currently unites 108 partners from 26 countries to prioritise and implement radiation protection research while strengthening capacity building and infrastructure sharing across Europe. Our mission is to advance scientific excellence, support evidence-based policymaking, and foster innovation to ensure the safe and sustainable use of ionising radiation across multiple sectors. We advocate that a strong emphasis on radiation protection is necessary to contribute to the quality of life in Europe (including human and ecosystem health), drive innovation and sustainable growth across Europe, and meet emerging challenges arising from new technologies and threats.

While ionising radiation enables breakthroughs in medicine, nuclear and non-nuclear industries, and energy, it also requires a strong research foundation to mitigate risks, enhance emergency preparedness, response, and recovery, support risk-proportionate regulatory frameworks, and keep practices up to date. Without continued investment, Europe risks policy fragmentation, delayed technological advancements, and missed opportunities for innovation.

The White Paper advocates for a dedicated €75 million funding envelope within FP10 EURATOM to sustain a PIANOFORTE-like partnership. This investment, restoring the Horizon 2020 baseline for EC-funded radiation protection research with a modest ~15% adjustment, forms an essential component of Europe's s strategy for competitiveness, security, and quality of life, including the quality of environmental resources and natural capital, notably complementing Horizon Europe's objectives in the context of the energy transition.

Our White Paper has now been distributed to key high-level officials, including elected European Commissioners whose portfolios relate to the societal impacts of radiation protection. It has also been shared with officials at the European Commission's s Directorate-General for Research and Innovation (DG RTD), particularly those focused on EURATOM Research, as well as the EURATOM Scientific and Technical Committee and its Working Group on Radiation Protection. Additionally, it has been sent to the Directorate-General for Energy (DG ENER), the EURATOM Article 31 Group of Experts, and the Science Attachés of the Permanent Representations of the 27 EU Member States.

We invite all stakeholders involved in all aspects of radiation protection, from research to practical implementation, to support this important initiative for the future of Europe. Read more about the White Paper.



News

SONORA at ICRPM
21.1.2026
SONORA Project was presented at the International Conference on Radiation Protection in Medicine - X Ray Vision
12th NERIS Workshop
13.1.2026
The 12th NERIS Workshop will take place at ASNR headquarters in Fontenay-aux-Roses, France on 28-29-30 April 2026.
8th MELODI Workshop Radiation Effects on the Immune System
13.1.2026
The 8th MELODI Workshop on “Radiation Effects on the Immune System” will be held on 28 and 29 April 2026 in Grenoble, France.
RRADEW's 2nd Consortium Workshop
8.1.2026
RRADEW's 2nd Consortium Workshop that took place on 17-18 November 2025 in Antwerp.
Stakeholder Consultation on the SRIA
7.10.2025
The SRIA outlines the strategic objectives and thematic priorities for research and innovation in the coming years.
SONORA project at the RSNA 2025
30.11.-4.12.2025
SONORA project at the RSNA 2025 (Radiological Society of North America) held from November 30-December 4 in Chicago

Subscribe to our newsletter

Aims and goals



Improving patient radiation protection in relation to the use of ionizing radiation in the medical field.


Better comprehension of variability of individual response to exposure to ionizing radiation.


The study of mechanisms involved in chronic exposure to low doses of ionizing radiation.


The improvement of anticipation capacities and resilience in nuclear or radiological crisis situations and post-accident management.

101
partners
28
countries
17
research projects
46
mil €
budget